Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Adipokines-A Cohort Prospective Study in Children with Severe Burns.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • الموضوع:
    • نبذة مختصرة :
      Burns generate every year an important burden of morbidity, being a major global public health problem through prolonged hospitalization, complications, and increased mortality. This study's purpose was to evaluate the serum levels of three adipokines and to establish significant correlations with other circulating molecules and with some clinical parameters. We evaluated 32 children with severe burns (over 25% total burned surface area-TBSA) at 48 h, day 10, and day 21 post burn, and 21 controls. The serum levels of adiponectin, resistin, leptin, tumor necrosis factor-α (TNF-α), plasminogen activator inhibitor-1 (PAI-1), and C-reactive protein (CRP) (among nine other biochemical parameters) were detected by Multiplex technique. Significant statistical differences were obtained for resistin and leptin compared to the control group, in different moments of measurements. Adiponectin serum levels presented statistically significant correlations with hot liquid mechanism of burn, the Revised Baux score, TBSA, resistin, PAI-1, CRP, TNF-α, and triglycerides (TGLs) serum levels. Resistin serum levels presented statistically significant correlations with adiponectin, CRP, PAI-1, leptin, and TNF-α. Additionally, we found statistically significant correlations between leptin serum levels and length of hospitalization, TNF-α, resistin, adiponectin, and PAI-1 serum levels. In severely burned children, adiponectin, resistin, and leptin specifically correlate with clinical parameters and with proteins involved in the systemic inflammatory response and the hypermetabolic response.
    • References:
      Respiration. 2004 Jan-Feb;71(1):45-50. (PMID: 14872110)
      Burns. 2020 Mar;46(2):259-266. (PMID: 30826149)
      Endocrine. 2016 Mar;51(3):456-68. (PMID: 26407855)
      Clin Immunol. 2009 Nov;133(2):157-70. (PMID: 19740705)
      J Endocrinol Invest. 2011 Feb;34(2):e36-42. (PMID: 20671416)
      JPEN J Parenter Enteral Nutr. 1998 Nov-Dec;22(6):340-6. (PMID: 9829605)
      Nat Rev Neurosci. 2018 Feb 16;19(3):153-165. (PMID: 29449715)
      Diabetes. 2008 Jul;57(7):1824-33. (PMID: 18375436)
      Int J Mol Sci. 2019 Mar 08;20(5):. (PMID: 30857216)
      Front Physiol. 2020 Oct 30;11:578966. (PMID: 33192583)
      J Trauma Acute Care Surg. 2017 Sep;83(3):507-519. (PMID: 28697011)
      Circulation. 2005 Feb 22;111(7):932-9. (PMID: 15710760)
      Cell. 2015 Sep 24;163(1):84-94. (PMID: 26406372)
      Front Physiol. 2021 Feb 18;12:639417. (PMID: 33679451)
      Sci Rep. 2023 Aug 21;13(1):13600. (PMID: 37604951)
      J Vasc Surg. 2019 Feb;69(2):497-506. (PMID: 30292618)
      Cytokine. 2013 Jan;61(1):78-83. (PMID: 23021431)
      Nutrients. 2023 Sep 19;15(18):. (PMID: 37764842)
      Ann Transl Med. 2020 Sep;8(17):1053. (PMID: 33145272)
      Cells. 2020 Jun 01;9(6):. (PMID: 32492888)
      Domest Anim Endocrinol. 2017 Oct;61:62-76. (PMID: 28715671)
      Diab Vasc Dis Res. 2014 Mar;11(2):121-4. (PMID: 24396117)
      Atherosclerosis. 2006 Sep;188(1):184-9. (PMID: 16325822)
      Burns. 2023 Feb;49(1):1-14. (PMID: 35843806)
      Int J Obes Relat Metab Disord. 2000 Jun;24(6):789-93. (PMID: 10878688)
      Int J Mol Sci. 2023 Sep 16;24(18):. (PMID: 37762481)
      Int J Environ Res Public Health. 2022 Sep 28;19(19):. (PMID: 36231617)
      J Neurosci. 2014 Apr 16;34(16):5486-96. (PMID: 24741039)
      Diagnostics (Basel). 2023 Sep 18;13(18):. (PMID: 37761351)
      Int J Mol Sci. 2024 Feb 16;25(4):. (PMID: 38397015)
      BMC Endocr Disord. 2024 Mar 14;24(1):39. (PMID: 38481206)
      Front Nutr. 2022 Jul 12;9:921399. (PMID: 35903456)
      Int J Obes Relat Metab Disord. 2001 Dec;25(12):1759-66. (PMID: 11781755)
      J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72. (PMID: 18492747)
      Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):59-63. (PMID: 28138112)
      Int J Mol Sci. 2019 May 28;20(11):. (PMID: 31141984)
      Molecules. 2022 Jan 06;27(2):. (PMID: 35056647)
      Biochem Biophys Res Commun. 2005 Sep 9;334(4):1092-101. (PMID: 16039994)
      Int J Obes Relat Metab Disord. 1999 Apr;23(4):355-60. (PMID: 10340812)
      Front Cell Neurosci. 2020 Sep 30;14:565841. (PMID: 33192311)
      Biochem Biophys Res Commun. 2010 Jan 29;392(1):47-52. (PMID: 20051227)
      Cytokine X. 2022 Jan 22;4(1):100064. (PMID: 35128381)
      Adipocyte. 2018 Jan 2;7(1):57-62. (PMID: 29205099)
      Biol Chem. 2021 Jul 29;402(9):1129-1145. (PMID: 34323429)
      J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1569-S1572. (PMID: 35018031)
      Nat Metab. 2021 Oct;3(10):1302-1312. (PMID: 34650277)
      Ann Burns Fire Disasters. 2007 Jun 30;20(2):89-100. (PMID: 21991076)
      J Pharm Bioallied Sci. 2023 Jul;15(Suppl 1):S31-S35. (PMID: 37654317)
      Diabetes Metab Syndr. 2014 Jul-Sep;8(3):152-5. (PMID: 25042166)
      Int J Mol Sci. 2020 Aug 21;21(17):. (PMID: 32839413)
      Burns. 2020 Mar;46(2):493-496. (PMID: 31711801)
      Am J Hypertens. 2022 Apr 2;35(4):311-318. (PMID: 34525175)
      Front Immunol. 2017 Nov 28;8:1675. (PMID: 29234328)
      Lancet. 2016 Oct 1;388(10052):1417-1426. (PMID: 27707498)
      Int J Mol Sci. 2020 Feb 12;21(4):. (PMID: 32059381)
      Aging (Albany NY). 2019 Jan 21;11(2):303-327. (PMID: 30669119)
      Afr Health Sci. 2017 Mar;17(1):99-107. (PMID: 29026382)
      Burns. 2003 Aug;29(5):449-53. (PMID: 12880724)
      Semin Thromb Hemost. 2023 Apr;49(3):305-313. (PMID: 36522166)
      Cell Rep. 2020 Oct 20;33(3):108275. (PMID: 33086075)
      Mech Ageing Dev. 2019 Mar;178:46-63. (PMID: 30650338)
      J Clin Med. 2024 May 09;13(10):. (PMID: 38792336)
      Cells. 2023 Jul 07;12(13):. (PMID: 37443835)
      Biomedicines. 2023 Apr 27;11(5):. (PMID: 37238961)
      Hepatol Commun. 2018 Sep 26;2(12):1479-1492. (PMID: 30556037)
      Biochem Biophys Res Commun. 2014 May 30;448(2):129-33. (PMID: 24667608)
      Front Endocrinol (Lausanne). 2023 Oct 03;14:1215353. (PMID: 37854189)
      Front Immunol. 2021 Nov 09;12:703515. (PMID: 34858392)
      Nat Metab. 2019 Aug;1(8):754-764. (PMID: 32694767)
      J Biol Chem. 2002 Jan 11;277(2):1085-91. (PMID: 11694522)
      Arch Med Sci Atheroscler Dis. 2022 Aug 31;7:e124-e130. (PMID: 36158069)
      BMC Anesthesiol. 2014 Dec 18;14:124. (PMID: 25580089)
      Front Immunol. 2020 Nov 25;11:585880. (PMID: 33324405)
      Burns. 2022 Nov;48(7):1680-1689. (PMID: 34961651)
      Endocrinology. 2005 Aug;146(8):3334-42. (PMID: 15905315)
      Rev Endocr Metab Disord. 2022 Feb;23(1):13-30. (PMID: 34523036)
      Int J Prev Med. 2013 Feb;4(2):133-40. (PMID: 23543874)
    • Contributed Indexing:
      Keywords: adipokines; adiponectin; leptin; resistin; severe burns; tumor necrosis factor-α (TNF-α)
    • الرقم المعرف:
      0 (Adipokines)
      0 (Leptin)
      9007-41-4 (C-Reactive Protein)
      0 (Resistin)
      0 (Plasminogen Activator Inhibitor 1)
      0 (Tumor Necrosis Factor-alpha)
      0 (Biomarkers)
      0 (Adiponectin)
      0 (RETN protein, human)
    • الموضوع:
      Date Created: 20240727 Date Completed: 20240727 Latest Revision: 20240729
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC11277113
    • الرقم المعرف:
      10.3390/ijms25147630
    • الرقم المعرف:
      39062875